Government Affairs
Refine Search
Pharmaceutical
The Ukrainian government is considering imposing a ban on the import of drugs from Russia. This comes as a response to economic sanctions that were recently imposed by Russia on some Ukrainian goods. 13 November 2014
Pharmaceutical
Germany and the UK have agreed a joint proposal to advance the negotiations on new rules for preferential intellectual property (IP) regimes within the G20/OECD BEPS (Base erosion and profit shifting) Project, relating to tax breaks for intellectual property. 13 November 2014
Pharmaceutical
New legislation known as Vanessa’s Law (Bill C 17; the Protecting Canadians from Unsafe Drugs Act) has received Royal Assent and is now law, Canadian Minister of Health Rona Ambrose has announced. 11 November 2014
Generics
An American pharmacist and an Indian pharmacologist charged with smuggling four million fake pharmaceuticals into the country earlier this month may have been the last straw for the Indian government battling counterfeit drugs. 10 November 2014
Pharmaceutical
The Pharmaceuticals Industry Council, a collaboration representing Australian biotech and pharma industry bodies, and consisting of AusBiotech, the Generic Medicines Industry Association and Medicines Australia, has ceased operations. 3 November 2014
Pharmaceutical
The Russian National Parliament (State Duma) plans to impose a ban on the imports of unregistered drugs to Russia with the purpose of sales and making a profit in the country, according to the press-service of the Duma. 30 October 2014
Pharmaceutical
The pressure from the US government on India seems to be working. With India's intellectual property rights (IPR) regime facing flak, and the USA launching an out-of-cycle review of India's IPR regime, the Department of Industrial Policy and Promotion (DIPP) has set up a think-tank to draft a National Intellectual Property Rights Policy. 27 October 2014
Pharmaceutical
The Russian government is considering introducing state regulation of prices for drugs in the country, reports The Pharma Letter’s Russia correspondent. 27 October 2014
Pharmaceutical
Leading Ukrainian pharmaceutical producers and importers have sent an official letter to the national government asking it to abolish the recently adopted directive from the Ukrainian National Bank (UNB) about the currency restrictions. 21 October 2014
Pharmaceutical
Access to affordable cancer treatments in the USA and 11 other countries would be delayed for years if terms revealed today in the leaked draft Intellectual Property Chapter of the Trans-Pacific Partnership (TPP) were to go into effect, US consumer advocacy Public Citizen said. 17 October 2014
Pharmaceutical
Jean-Claude Juncker, President-elect of the European Commission, has backtracked on his decision to return control of medicines and pharma products to the Industry Commissioner. 14 October 2014
Pharmaceutical
AIDS Healthcare Foundation (AHF), the largest global AIDS organization, with its affiliate country program, AHF India, today urged Indian Prime Minister Narendra Modi to restore drug pricing caps in India that he recently overturned, a move that advocates fear will make making lifesaving medicines less affordable in that country. 14 October 2014
Pharmaceutical
The Australian government’s Industry Innovation and Competitiveness Agenda and the announcement of five industry growth centers released today has been welcomed by trade group Medicines Australia’s chairman Martin Cross. 14 October 2014
Generics
Letters have been sent to 14 drug manufacturers, including several major Indian firms, requesting information about the escalating prices they have been charging for generic drugs in the USA by Congressmen. 10 October 2014
Pharmaceutical
US trade group the Pharmaceutical Research and Manufacturers of America (PhRMA) has released a new report, titled Researching Cancer Medicines: Setbacks and Stepping Stones, which highlights the number of investigational cancer medicines that did not succeed in clinical trials and how these so-called “failures” are a critical part of the drug development process. 8 October 2014
Generics
Canadian trade group Research-Based Pharmaceutical Companies (Rx&D) expressed its support to the government of Canada as it reached another milestone in the finalization of the Comprehensive Economic and Trade Agreement (CETA) with the release of text at the Canada-EU Summit held today in Ottawa. 29 September 2014
Generics
The India Brand Equity Foundation (IBEF), on behalf of the government of India, has taken strong objection to a smear campaign being orchestrated by the Washington-based American Enterprise Institute (AEI) against the whole Indian pharmaceutical industry. 26 September 2014
Pharmaceutical
Trade group the European Federation of Pharmaceutical Industries and Associations (EFPIA) claims that there has been a strengthening of the pharma industry’s commitment in China, following a recent delegation visit to Beijing. 26 September 2014
Pharmaceutical
The Russian government may take a decision about the imposition of restrictions on the participation of foreign companies in tenders for the purchase of drugs for state needs already in the middle of October of the current year, according to an official spokesperson in the Russian government. 23 September 2014
Pharmaceutical
The USA’s Department of the Treasury announced on Monday that it is taking action to reduce the tax benefits of - and when possible, stop - corporate tax inversions. This action will significantly diminish the ability of inverted companies to escape US taxation. 23 September 2014
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze